REQUEST A DEMO
Total
USD $0.00
Search more companies

Msd Korea Ltd. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Msd Korea Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

MSD Korea LTD. is a bio-pharmaceutical company. The company develops medicines and vaccines for various diseases, including cancer, infectious diseases, and new animal illnesses. MSD Korea LTD. focuses on acute diseases, diabetes, and anti-cancer vaccines, and it aims to support domestic medical development.

Headquarters
23th Floor, 416, Hangang-daero Jung-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Msd Korea Ltd. report to view the information.

Website: http://www.msd-korea.com

Basic Information
Total Employees:
Purchase the Msd Korea Ltd. report to view the information.
Outstanding Shares:
Purchase the Msd Korea Ltd. report to view the information.
Registered Capital:
Purchase the Msd Korea Ltd. report to view the information.
Incorporation Date:
April 13, 1994
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Msd Korea Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
51.38%
Total operating revenue
51.38%
Operating profit (EBIT)
-50.67%
EBITDA
-50.05%
Net Profit (Loss) for the Period
-69.96%
Total assets
6.13%
Total equity
17.32%
Operating Profit Margin (ROS)
-7.21%
Net Profit Margin
-9.01%
Return on Equity (ROE)
-40.43%
Quick Ratio
-0.08%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?